Literature DB >> 5087876

The activated coagulation time of whole blood as a routine pre-operative sceening test.

P G Hattersley.   

Abstract

Patients with disorders of hemostasis who undergo surgical procedures are in danger of hemorrhage. While the careful medical history remains the most sensitive test of a bleeding tendency, some such patients can give no suggestive history. In three patients with coagulopathy-one with mild classical hemophilia, one with Christmas disease, and one with warfarin toxicity-the abnormality was missed by routine preoperative history but promptly detected by the routine preoperative use of the activated coagulation time (act). Either this test or the activated partial thromboplastin time should be included in the routine preoperative work-up, along with appropriate additional tests of the hemostatic mechanism.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5087876      PMCID: PMC1502002     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  6 in total

1.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

2.  An improved one-stage prothrombin method.

Authors:  A G WARE; R STRAGNELL
Journal:  Am J Clin Pathol       Date:  1952-08       Impact factor: 2.493

3.  Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report.

Authors:  P G Hattersley; M L Dimick
Journal:  Transfusion       Date:  1969 Sep-Oct       Impact factor: 3.157

4.  Production of high-potency concentrates of antihemophilic globulin in a closed-bag system.

Authors:  J G Pool; A E Shannon
Journal:  N Engl J Med       Date:  1965-12-30       Impact factor: 91.245

5.  Activated coagulation time of whole blood.

Authors:  P G Hattersley
Journal:  JAMA       Date:  1966-05-02       Impact factor: 56.272

6.  The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests.

Authors:  P G Hattersley
Journal:  JAMA       Date:  1966-10-17       Impact factor: 56.272

  6 in total
  2 in total

1.  Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.

Authors:  Martin Kreuzer; Thurid Ahlenstiel; Nele Kanzelmeyer; Jochen H H Ehrich; Lars Pape
Journal:  Pediatr Nephrol       Date:  2010-03-11       Impact factor: 3.714

2.  Assessing thrombin generation at the point of care.

Authors:  T Keith Brock; Nicole L Gentile; Richard F Louie; Nam K Tran; Tyler Kitano; Gerald J Kost
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.